{"transactions":[{"id":2013186,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-15T17:53:39.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":934645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":934645,"derivative":{"exercise_price":0.142,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":934645},"source":{"system":"sec-edgar","filing":"0001209191-23-009634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919123009634/doc4.xml","form_type":"4"}},{"id":2186563,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-12T13:43:31.000Z","date":"2022-08-10","kind":"purchase","acquired":true,"shares":5000,"price":0.2545,"value":1272.5,"ownership":{"direct":true},"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001209191-22-045524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122045524/doc4.xml","form_type":"4"}},{"id":2337195,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-11T16:23:47.000Z","date":"2022-03-10","kind":"purchase","acquired":true,"shares":10000,"price":0.37,"value":3700.0,"ownership":{"direct":true},"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001209191-22-018101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122018101/doc4.xml","form_type":"4"}},{"id":2415830,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:55:52.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":402900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":402900,"derivative":{"exercise_price":0.47,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":402900},"source":{"system":"sec-edgar","filing":"0001209191-22-006519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122006519/doc4.xml","form_type":"4"}},{"id":2878729,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T21:31:00.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":307300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a special retention award comprised of options to purchase common stock. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022"}],"balance_after":307300,"derivative":{"exercise_price":2.58,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":307300},"source":{"system":"sec-edgar","filing":"0001209191-21-007736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121007736/doc4.xml","form_type":"4"}},{"id":2878728,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T21:31:00.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":307300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022."}],"balance_after":307300,"derivative":{"exercise_price":2.58,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":307300},"source":{"system":"sec-edgar","filing":"0001209191-21-007736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121007736/doc4.xml","form_type":"4"}},{"id":3201811,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-18T17:18:00.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":2000,"price":4.25,"value":8500.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-20-019954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/doc4.xml","form_type":"4"}},{"id":3219828,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2020-03-09T21:28:40.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 6, 2021, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 6, 2021."}],"balance_after":226000,"derivative":{"exercise_price":4.53,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0001209191-20-017408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120017408/doc4.xml","form_type":"4"}},{"id":3374004,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-11-12T16:07:58.000Z","date":"2019-11-11","kind":"purchase","acquired":true,"shares":1000,"price":4.38,"value":4380.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-055930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/doc4.xml","form_type":"4"}},{"id":3435747,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-08-16T13:50:53.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":1500,"price":5.4753,"value":8212.95,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-19-046252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/doc4.xml","form_type":"4"}},{"id":3439684,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-08-13T13:48:42.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":1500,"price":6,"value":9000.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-19-045684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/doc4.xml","form_type":"4"}},{"id":3525610,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-05-15T13:56:24.000Z","date":"2019-05-14","kind":"purchase","acquired":true,"shares":1000,"price":7.2266,"value":7226.6,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-029852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/doc4.xml","form_type":"4"}},{"id":3592402,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-03-15T14:32:44.000Z","date":"2019-03-14","kind":"purchase","acquired":true,"shares":5000,"price":6.8517,"value":34258.5,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-019602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/doc4.xml","form_type":"4"}},{"id":3617733,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116829,"kind":"person","name":"Millian Craig Stuart","position":1,"cik":"0001769163","reported_name":"Millian Craig Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2019-03-04T23:44:54.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 28, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 28, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 28, 2020."}],"balance_after":180000,"derivative":{"exercise_price":6.94,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-19-015958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119015958/doc4.xml","form_type":"4"}}]}